Universe Pharmaceuticals INC
UPC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001809616
No open-market purchases or sales by Universe Pharmaceuticals INC insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $228.4K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Universe Pharmaceuticals INC changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 3 | 1 | −2 |
| Shares | 563.8K | 266 | −563.6K (−100.0%) |
| Value | $343.9K | $1.09K | −$342.8K (−99.7%) |
New holders (1)
Institutions that held Universe Pharmaceuticals INC at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 266 | $1.09K | 0.00% |
Sold out (3)
Institutions that held Universe Pharmaceuticals INC at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sabby Management, LLC | 333,355 | $203.3K |
| Anson Funds Management LP | 230,407 | $140.5K |
| Morgan Stanley | 65 | $40 |